Furthermore, Nrf2/HO-1 activated in human placental trophoblasts cells reduces the production of the anti-angiogenic factor soluble fms-like tyrosine kinase-1 (sFlt-1) and improves endothelial dysfunction [25]. The gene discussed is HMOX1; the disease is endothelial dysfunction.